(HealthDay)—Children with amblyopia have significantly lower mean peer acceptance and physical competence scores at age 3 to 7 years, according to a study published online Feb. 14 in JAMA Ophthalmology.
Feb 19, 2019
0
5
A new study indicates that both high-grade abnormal cellular changes (dysplasia) and esophageal adenocarcinoma (a form of cancer) have increased in the last 25 years among people with a digestive condition known as Barrett's ...
Feb 14, 2019
0
1
A new brain tumour model to provide more realistic test responses to chemo and radiotherapy is being developed by NSW scientists.
Feb 14, 2019
0
0
(HealthDay)—In prostate cancer, patient- and clinician-based cumulative toxicity scores comprising all-grade adverse events (AEs) better reflect the impact on patient quality of life (QoL) than scores comprising high-grade ...
Jan 9, 2019
0
0
The shift from film to digital mammography increased the detection of breast cancer by 14 percent overall in the United Kingdom without increasing the recall rate, according to a major new study appearing in the journal Radiology.
Dec 11, 2018
0
0
Vanderbilt University Medical Center is participating in an international study to determine the effectiveness of a new therapeutic vaccine for treating women with precancerous changes on the cervix.
Dec 10, 2018
0
4
For African-American youths, their academic performance in middle school is influenced by more than what happens at home—their neighborhood experiences also affect how they perform in school.
Dec 5, 2018
0
5
Identifying factors that predict academic difficulties during elementary school should help inform efforts to help children who may be at risk. New Penn State research suggests that children's executive functions may be a ...
Nov 19, 2018
0
0
The "gateway pattern" of adolescent substance use is changing, and marijuana is increasingly the first substance in the sequence of adolescent drug use, according researchers at the Columbia University Mailman School of Public ...
Nov 19, 2018
1
3
UCSF Benioff Children's Hospitals are harnessing next-generation genomic technology to develop individualized drug cocktails in a new trial for children with a type of malignant brain tumor. This precision-medicine approach ...
Aug 30, 2018
0
8
